on 21 Oct 2022
Last Applicant/ Owned by
CH-4002 Basel
CH
Serial Number
79248061 filed on 06th Nov 2018
Registration Number
5816161 registered on 30th Jul 2019
Correspondent Address
Novartis Pharma AG,; Trademark Departmen
Filing Basis
No Filing Basis
Disclaimer
NO DATA
In the statement, class 5 has been corrected per the Restriction dated 10/3/19, and per the fnote dated 10/17/19. [ Anti-infectives; ] anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diRead More
[ Anti-infectives; ] anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; [ pharmaceutical preparations acting on the central nervous system; ] pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; [ pharmaceutical preparations for the prevention and treatment of cancer and tumors; ] pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma * ; except in the fields of oncology, infectious diseases and diseases of the central nervous system *
No 79248061
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 19th Jan 2023 | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
| 06th Nov 2022 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
| 06th Nov 2022 | DEATH OF INTERNATIONAL REGISTRATION |
| 03rd Jun 2022 | LIMITATION FROM THE IB EXAMINED AND ENTERED |
| 29th May 2022 | CORRECTION UNDER SECTION 7 ¿ PROCESSED |
| 06th Jul 2020 | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE |
| 18th Jun 2020 | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |
| 19th Oct 2019 | LIMITATION FROM THE IB EXAMINED AND ENTERED |
| 18th Oct 2019 | CORRECTION UNDER SECTION 7 ¿ PROCESSED |
| 04th Oct 2019 | NOTIFICATION PROCESSED BY IB |
